GPs’ breast cancer guidelines ‘miss’ 95% of young women who will develop disease
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"GPs’ breast cancer guidelines ‘miss’ 95% of young women who will develop disease" is generating significant coverage in the Health category, with 3 articles from 3 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The New York Times, The Independent and BBC. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 103d ago.
Quick answers
Why is "GPs’ breast cancer guidelines ‘miss’ 95% of young women who will develop disease" trending?
Because 3 independent news sources published 3 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- San Diego executives lead efforts to improve women's heart health www.heart.org · 104d ago
- Healthcare executive at the forefront of local women’s heart health movement www.heart.org · 104d ago
- Why Are More Young Women Developing Heart Disease? The New York Times · 104d ago
- The breast cancer blind spot The Independent · 106d ago
- Breast cancer checks missing most women under 50 who are at risk, says study BBC · 106d ago
Topics
Related trends
Sellas’ experimental blood cancer immunotherapy reduced risk of death in clinical trial
SELLAS Life Sciences' GPS vaccine demonstrated a 41% reduction in death risk and nine-month survival benefit in a pivotal Phase 3 AML trial, sending shares up 220%.
Garmin Sales Begin: Huge deals on Garmin Fenix, Edge, Forerunner Series and more!
Garmin has launched Black Friday and holiday-season sales on Fenix, Edge, Forerunner and other products.
This Satellite Startup Working On A GPS Alternative Is Now Valued At Nearly $2.5 Billion
Satellite navigation startup Xona achieves a near $2.5 billion valuation following a $250 million fundraising round.
GPS Glitched Across The US by as Much as 33 Feet. Scientists Have Never Seen This Before.
Scientists have identified the cause of a solar superstorm that shifted US GPS accuracy by up to 33 feet, a disruption described as unprecedented.
Artemis II Rocket Was Powerful Enough To Disrupt GPS
Coverage indicates the Artemis II rocket generated enough power during launch to disrupt GPS operations.
NASA rocket may have punched a hole in the atmosphere, here's how it could impact GPS signals
Recent coverage examines whether NASA's Artemis II rocket launch punched a hole in the atmosphere and its potential impact on GPS signals.